Browse Data and Analysis

Despite being one of the largest oil palm-producing countries, Nigeria relies on imports to bridge its supply gap. Private sector investors are expanding oil palm production and increasing processing capacity to take advantage of the prevailing strong domestic and international market demand and high prices.

Nigeria continues to strive for self-sufficiency in oil palm production. Currently, production remains stable. Meanwhile, demand for palm oil outweighs supply. Nigeria meets the supply gap in oil palm through imports from Malaysia, China, and Côte d’Ivoire.

There is no legal impediment to the use of biotechnology in El Salvador. Genetically engineered (GE) corn field trials were successfully completed.

Salvadoran restaurants and hotels continue to benefit from growth in the tourism sector, especially the business/convention and emerging surf sectors.

During 2019, the Salvadoran retail sector, valued at approximately $4.5 billion, continues to show positive signs of growth as supermarkets and discount stores have expanded operations.

The West African nations of Côte d’Ivoire, The Gambia, Ghana, Nigeria, and Senegal are home to some of the largest cities in the region...

In June 2019, the Nigerian government formulated a new policy to invest some $500 million in expanded palm oil production.

Nigeria’s animal feed sector remains underdeveloped, largely due to high production costs.

Since the United States entered into the CAFTA-DR trade agreement, U.S. agricultural exports to the six CAFTA-DR countries have more than doubled.

Central America and the Caribbean, with their close geographical and economic ties to the United States, have always been an important market for U.S. agricultural exports.

In 2008, El Salvador abolished the Planting Seed Law that required imported seeds to have a phytosanitary certificate with an additional declaration stating that the seeds did not contain GMOs.

El Salvador has no legal restriction on the use of agricultural biotechnology. However the country's biotech regulatory framework is still being developed.